ICMRA Review Finds Remote Alternatives Could Complement Onsite Inspections, Not Replace Them
Stance echoes US FDA’s view that remote alternatives should be “supplemental tools” to support in-person inspections.
Stance echoes US FDA’s view that remote alternatives should be “supplemental tools” to support in-person inspections.